These results suggested that glucocorticoid‐transactivated TSC22D3 suppressed hypoxia‐ and diabetes‐induced galectin‐1 expression via destabilization of HIF‐1α protein (Figure 6). This evidence concerns the gene TSC22D3 and diabetes mellitus.